We have expanded the list of climate policies we assess company engagement with to incorporate land-use related policy, referring to legislative or regulatory measures to enhance and protect ecosystems and land where carbon is being stored. Assessments under this category are currently underweighted in terms of their contribution to the overall company metrics. This weighting will be progressively increased over the next 6 months.
We adjusted the terminology used to describe the queries running down the left-hand side of our scoring matrix and added additional explanatory text to the info-boxes. This has no impact on the scores and methodology. It has been done following user feedback to improve clarity.
Climate Lobbying Overview: Japan Pharmaceutical Association appears to have no recent direct engagement with climate and energy policy in Japan.
Top-line Messaging on Climate Policy: Japan Pharmaceutical Association does not appear to have disclosed its engagement with climate policy in the recent years.
Engagement with Climate-Related Regulations: InfluenceMap has found no evidence on Japan Pharmaceutical Association’s recent positions towards, or engagement with, climate related regulations.
Positioning on Energy Transition: InfluenceMap has not found evidence on Japan Pharmaceutical Association’s positions towards, or engagement with, the energy transition.